Tapewire

Nasdaq · USD

CUE

Cue Biopharma, Inc.

Export transactions ↓
Tapewire entity
6301
SEC CIK
0001645460
Parsed reports
259

Last 12 months

Inside the activity.

5 purchase rows · 15 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202550
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 2026011
Sep 202600
Oct 202604

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 12, 2026 Filed Oct 15, 2026 01:39 UTC
Ray SumitaChief Legal Compliance Officer · Corporate Secretary
SaleCommon Stock 1,844 $28.05 $51,724.20
Disclosure

SEC source: 0001579629-26-000012 · form4-10152026_011030.xml · nonDerivative · entry 1

Ray Sumita · CIK 0001579629 · Chief Legal Compliance Officer · Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,701

F1 · kind: The sales reported represent shares sold pursuant to the Issuer's Company-Wide Policy and do not represent discretionary transactions by the Reporting Person. These sales were made automatically to satisfy mandatory tax withholding obligations through a "sell-to-cover" transaction in connection with the vesting and settlement of restricted stock units, and the Reporting Person did not exercise any control over the timing, price or number of shares sold.

Read SEC document
October 12, 2026 Filed Oct 15, 2026 01:38 UTC
Meluzio Michael VincentVP, Prin. Accounting Officer
SaleCommon Stock 1,144 $28.05 $32,089.20
Disclosure

SEC source: 0002138368-26-000009 · form4-10152026_011010.xml · nonDerivative · entry 1

Meluzio Michael Vincent · CIK 0002138368 · VP, Prin. Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,817

F1 · kind: The sales reported represent shares sold pursuant to the Issuer's Company-Wide Policy and do not represent discretionary transactions by the Reporting Person. These sales were made automatically to satisfy mandatory tax withholding obligations through a "sell-to-cover" transaction in connection with the vesting and settlement of restricted stock units, and the Reporting Person did not exercise any control over the timing, price or number of shares sold.

Read SEC document
October 12, 2026 Filed Oct 15, 2026 01:37 UTC
Lin Shao-LeeDirector · Chief Executive Officer
SaleCommon Stock 1,087 $28.05 $30,490.35
Disclosure

SEC source: 0001725092-26-000019 · form4-10152026_011031.xml · nonDerivative · entry 2

Lin Shao-Lee · CIK 0001725092 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 694,908

F1 · kind: The sales reported represent shares sold pursuant to the Issuer's Company-Wide Policy and do not represent discretionary transactions by the Reporting Person. These sales were made automatically to satisfy mandatory tax withholding obligations through a "sell-to-cover" transaction in connection with the vesting and settlement of restricted stock units, and the Reporting Person did not exercise any control over the timing, price or number of shares sold.

Read SEC document
October 12, 2026 Filed Oct 15, 2026 01:37 UTC
Lin Shao-LeeDirector · Chief Executive Officer
SaleCommon Stock 10,000 $27.50 $275,000.00
Disclosure

SEC source: 0001725092-26-000019 · form4-10152026_011031.xml · nonDerivative · entry 1

Lin Shao-Lee · CIK 0001725092 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 695,995

F1 · kind: The sales reported represent shares sold pursuant to the Issuer's Company-Wide Policy and do not represent discretionary transactions by the Reporting Person. These sales were made automatically to satisfy mandatory tax withholding obligations through a "sell-to-cover" transaction in connection with the vesting and settlement of restricted stock units, and the Reporting Person did not exercise any control over the timing, price or number of shares sold.

Read SEC document
August 13, 2026 Filed Aug 15, 2026 00:46 UTC
Lin Shao-LeeDirector · Chief Executive Officer
SaleCommon Stock 10,460 $29.48 $308,360.80
Disclosure

SEC source: 0001725092-26-000013 · form4-08152026_120800.xml · nonDerivative · entry 6

Lin Shao-Lee · CIK 0001725092 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 705,995

F1 · kind: The sales reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a "sell-to-cover" transaction and do not represent discretionary transactions by the reporting person.

F6 · price: The price reported in this line item is a weighted average price. These shares were sold as part of block trades for multiple security holders of the Issuer at prices ranging from $28.90 to $29.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein to the block trades.

Read SEC document
August 13, 2026 Filed Aug 15, 2026 00:46 UTC
Lin Shao-LeeDirector · Chief Executive Officer
SaleCommon Stock 2,375 $28.11 $66,761.25
Disclosure

SEC source: 0001725092-26-000013 · form4-08152026_120800.xml · nonDerivative · entry 5

Lin Shao-Lee · CIK 0001725092 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 716,455

F1 · kind: The sales reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a "sell-to-cover" transaction and do not represent discretionary transactions by the reporting person.

F5 · price: The price reported in this line item is a weighted average price. These shares were sold as part of block trades for multiple security holders of the Issuer at prices ranging from $27.78 to $28.505, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein to the block trades.

Read SEC document
August 13, 2026 Filed Aug 15, 2026 00:46 UTC
Lin Shao-LeeDirector · Chief Executive Officer
SaleCommon Stock 5,423 $27.19 $147,451.37
Disclosure

SEC source: 0001725092-26-000013 · form4-08152026_120800.xml · nonDerivative · entry 4

Lin Shao-Lee · CIK 0001725092 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 718,830

F1 · kind: The sales reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a "sell-to-cover" transaction and do not represent discretionary transactions by the reporting person.

F4 · price: The price reported in this line item is a weighted average price. These shares were sold as part of block trades for multiple security holders of the Issuer at prices ranging from $26.70 to $27.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein to the block trades.

Read SEC document
August 13, 2026 Filed Aug 17, 2026 22:22 UTC
Ray SumitaChief Legal Compliance Officer · Corporate Secretary
Exercise / conversionCommon Stock · Derivative 18,196 $0.00 $0.00
Disclosure

SEC source: 0001579629-26-000008 · form4-08172026_100832.xml · derivative · entry 5

Ray Sumita · CIK 0001579629 · Chief Legal Compliance Officer · Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,393

Underlying: Common Stock · 18,196 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The performance stock units ("PSU") were awarded subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration. The award settled with respect to 1/3 of the PSUs underlying the award on August 13, 2026. The remaining 2/3 of the PSUs underlying the award are expected to settle on the achievement of a closing price per share of $38.50 and $44.00, in each case for a period of five consecutive trading days.

F4 · derivative.exercise_date: The performance stock units ("PSU") were awarded subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration. The award settled with respect to 1/3 of the PSUs underlying the award on August 13, 2026. The remaining 2/3 of the PSUs underlying the award are expected to settle on the achievement of a closing price per share of $38.50 and $44.00, in each case for a period of five consecutive trading days.

F4 · derivative.expiration_date: The performance stock units ("PSU") were awarded subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration. The award settled with respect to 1/3 of the PSUs underlying the award on August 13, 2026. The remaining 2/3 of the PSUs underlying the award are expected to settle on the achievement of a closing price per share of $38.50 and $44.00, in each case for a period of five consecutive trading days.

Read SEC document
August 13, 2026 Filed Aug 17, 2026 22:22 UTC
Ray SumitaChief Legal Compliance Officer · Corporate Secretary
SaleCommon Stock 4 $31.13 $124.52
Disclosure

SEC source: 0001579629-26-000008 · form4-08172026_100832.xml · nonDerivative · entry 4

Ray Sumita · CIK 0001579629 · Chief Legal Compliance Officer · Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,545

F1 · kind: The sales reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a "sell-to-cover" transaction and do not represent discretionary transactions by the reporting person.

Read SEC document
August 13, 2026 Filed Aug 17, 2026 22:22 UTC
Ray SumitaChief Legal Compliance Officer · Corporate Secretary
SaleCommon Stock 6,442 $30.35 $195,514.70
Disclosure

SEC source: 0001579629-26-000008 · form4-08172026_100832.xml · nonDerivative · entry 3

Ray Sumita · CIK 0001579629 · Chief Legal Compliance Officer · Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,549

F1 · kind: The sales reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a "sell-to-cover" transaction and do not represent discretionary transactions by the reporting person.

F3 · price: The price reported in this line item is a weighted average price. These shares were sold as part of block trades for multiple security holders of the Issuer at prices ranging from $29.99 to $30.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein to the block trades.

Read SEC document
August 13, 2026 Filed Aug 17, 2026 22:22 UTC
Ray SumitaChief Legal Compliance Officer · Corporate Secretary
SaleCommon Stock 2,383 $29.37 $69,988.71
Disclosure

SEC source: 0001579629-26-000008 · form4-08172026_100832.xml · nonDerivative · entry 2

Ray Sumita · CIK 0001579629 · Chief Legal Compliance Officer · Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,991

F1 · kind: The sales reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a "sell-to-cover" transaction and do not represent discretionary transactions by the reporting person.

F2 · price: The price reported in this line item is a weighted average price. These shares were sold as part of block trades for multiple security holders of the Issuer at prices ranging from $28.97 to $29.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein to the block trades.

Read SEC document
August 13, 2026 Filed Aug 17, 2026 22:22 UTC
Ray SumitaChief Legal Compliance Officer · Corporate Secretary
Exercise / conversionCommon Stock 18,196 $0.00 $0.00
Disclosure

SEC source: 0001579629-26-000008 · form4-08172026_100832.xml · nonDerivative · entry 1

Ray Sumita · CIK 0001579629 · Chief Legal Compliance Officer · Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 127,374

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 13, 2026 Filed Aug 17, 2026 22:19 UTC
Meluzio Michael VincentVP, Prin. Accounting Officer
Exercise / conversionCommon Stock · Derivative 13,647 $0.00 $0.00
Disclosure

SEC source: 0002138368-26-000007 · form4-08172026_100852.xml · derivative · entry 5

Meluzio Michael Vincent · CIK 0002138368 · VP, Prin. Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,295

Underlying: Common Stock · 13,647 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The performance stock units ("PSU") were awarded subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration. The award settled with respect to 1/3 of the PSUs underlying the award on August 13, 2026. The remaining 2/3 of the PSUs underlying the award are expected to settle on the achievement of a closing price per share of $38.50 and $44.00, in each case for a period of five consecutive trading days.

F4 · derivative.exercise_date: The performance stock units ("PSU") were awarded subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration. The award settled with respect to 1/3 of the PSUs underlying the award on August 13, 2026. The remaining 2/3 of the PSUs underlying the award are expected to settle on the achievement of a closing price per share of $38.50 and $44.00, in each case for a period of five consecutive trading days.

F4 · derivative.expiration_date: The performance stock units ("PSU") were awarded subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration. The award settled with respect to 1/3 of the PSUs underlying the award on August 13, 2026. The remaining 2/3 of the PSUs underlying the award are expected to settle on the achievement of a closing price per share of $38.50 and $44.00, in each case for a period of five consecutive trading days.

Read SEC document
August 13, 2026 Filed Aug 17, 2026 22:19 UTC
Meluzio Michael VincentVP, Prin. Accounting Officer
SaleCommon Stock 3 $31.13 $93.39
Disclosure

SEC source: 0002138368-26-000007 · form4-08172026_100852.xml · nonDerivative · entry 4

Meluzio Michael Vincent · CIK 0002138368 · VP, Prin. Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,961

F1 · kind: The sales reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a "sell-to-cover" transaction and do not represent discretionary transactions by the reporting person.

Read SEC document
August 13, 2026 Filed Aug 17, 2026 22:19 UTC
Meluzio Michael VincentVP, Prin. Accounting Officer
SaleCommon Stock 4,106 $30.35 $124,617.10
Disclosure

SEC source: 0002138368-26-000007 · form4-08172026_100852.xml · nonDerivative · entry 3

Meluzio Michael Vincent · CIK 0002138368 · VP, Prin. Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,964

F1 · kind: The sales reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a "sell-to-cover" transaction and do not represent discretionary transactions by the reporting person.

F3 · price: The price reported in this line item is a weighted average price. These shares were sold as part of block trades for multiple security holders of the Issuer at prices ranging from $29.99 to $30.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein to the block trades.

Read SEC document
August 13, 2026 Filed Aug 17, 2026 22:19 UTC
Meluzio Michael VincentVP, Prin. Accounting Officer
SaleCommon Stock 1,519 $29.37 $44,613.03
Disclosure

SEC source: 0002138368-26-000007 · form4-08172026_100852.xml · nonDerivative · entry 2

Meluzio Michael Vincent · CIK 0002138368 · VP, Prin. Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,070

F1 · kind: The sales reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a "sell-to-cover" transaction and do not represent discretionary transactions by the reporting person.

F2 · price: The price reported in this line item is a weighted average price. These shares were sold as part of block trades for multiple security holders of the Issuer at prices ranging from $28.97 to $29.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein to the block trades.

Read SEC document
August 13, 2026 Filed Aug 17, 2026 22:19 UTC
Meluzio Michael VincentVP, Prin. Accounting Officer
Exercise / conversionCommon Stock 13,647 $0.00 $0.00
Disclosure

SEC source: 0002138368-26-000007 · form4-08172026_100852.xml · nonDerivative · entry 1

Meluzio Michael Vincent · CIK 0002138368 · VP, Prin. Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,589

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 12, 2026 Filed Aug 15, 2026 00:46 UTC
Lin Shao-LeeDirector · Chief Executive Officer
Exercise / conversionCommon Stock · Derivative 109,179 $0.00 $0.00
Disclosure

SEC source: 0001725092-26-000013 · form4-08152026_120800.xml · derivative · entry 7

Lin Shao-Lee · CIK 0001725092 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 218,358

Underlying: Common Stock · 109,179 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: The performance stock units ("PSU") were awarded subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration. The award settled with respect to 1/3 of the PSUs underlying the award on August 12, 2026. The remaining 2/3 of the PSUs underlying the award are expected to settle on the achievement of a closing price per share of $38.50 and $44.00, in each case for a period of five consecutive trading days.

F7 · derivative.exercise_date: The performance stock units ("PSU") were awarded subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration. The award settled with respect to 1/3 of the PSUs underlying the award on August 12, 2026. The remaining 2/3 of the PSUs underlying the award are expected to settle on the achievement of a closing price per share of $38.50 and $44.00, in each case for a period of five consecutive trading days.

F7 · derivative.expiration_date: The performance stock units ("PSU") were awarded subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration. The award settled with respect to 1/3 of the PSUs underlying the award on August 12, 2026. The remaining 2/3 of the PSUs underlying the award are expected to settle on the achievement of a closing price per share of $38.50 and $44.00, in each case for a period of five consecutive trading days.

Read SEC document
August 12, 2026 Filed Aug 15, 2026 00:46 UTC
Lin Shao-LeeDirector · Chief Executive Officer
SaleCommon Stock 5,775 $27.75 $160,256.25
Disclosure

SEC source: 0001725092-26-000013 · form4-08152026_120800.xml · nonDerivative · entry 3

Lin Shao-Lee · CIK 0001725092 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 724,253

F1 · kind: The sales reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a "sell-to-cover" transaction and do not represent discretionary transactions by the reporting person.

F3 · price: The price reported in this line item is a weighted average price. These shares were sold as part of block trades for multiple security holders of the Issuer at prices ranging from $27.50 to $28.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein to the block trades.

Read SEC document
August 12, 2026 Filed Aug 15, 2026 00:46 UTC
Lin Shao-LeeDirector · Chief Executive Officer
SaleCommon Stock 34,225 $26.99 $923,732.75
Disclosure

SEC source: 0001725092-26-000013 · form4-08152026_120800.xml · nonDerivative · entry 2

Lin Shao-Lee · CIK 0001725092 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 730,028

F1 · kind: The sales reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a "sell-to-cover" transaction and do not represent discretionary transactions by the reporting person.

F2 · price: The price reported in this line item is a weighted average price. These shares were sold as part of block trades for multiple security holders of the Issuer at prices ranging from $26.50 to $27.495, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein to the block trades.

Read SEC document
August 12, 2026 Filed Aug 15, 2026 00:46 UTC
Lin Shao-LeeDirector · Chief Executive Officer
Exercise / conversionCommon Stock 109,179 $0.00 $0.00
Disclosure

SEC source: 0001725092-26-000013 · form4-08152026_120800.xml · nonDerivative · entry 1

Lin Shao-Lee · CIK 0001725092 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 764,253

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 30, 2026 Filed Aug 3, 2026 20:19 UTC
Ahlers James MChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 51,000 $0.00 Strike: $30.40 $0.00
Disclosure

SEC source: 0001320383-26-000006 · form4-08032026_080815.xml · derivative · entry 2

Ahlers James M · CIK 0001320383 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,000

Underlying: Common Stock · 51,000 shares

Expires 2036-07-30

F2 · derivative.exercise_date: The stock option becomes exercisable in equal quarterly installments over four years from July 30, 2026, subject to the reporting person's continued service with the issuer through each vest date.

Read SEC document
July 30, 2026 Filed Aug 3, 2026 20:19 UTC
Ahlers James MChief Financial Officer
GrantCommon Stock 25,500 $0.00 $0.00
Disclosure

SEC source: 0001320383-26-000006 · form4-08032026_080815.xml · nonDerivative · entry 1

Ahlers James M · CIK 0001320383 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,500

F1 · shares: Represents the grant of restricted stock units ("RSUs"). The shares subject to the RSU vest in equal quarterly installments over four years from July 30, 2026, subject to the reporting person's continued service with the issuer through each vest date.

Read SEC document
July 13, 2026 Filed Jul 15, 2026 22:59 UTC
Borie Dominique ChristianChief Medical Officer · Head of Research & Development
GrantStock Option (Right to Buy) · Derivative 63,000 $0.00 Strike: $30.92 $0.00
Disclosure

SEC source: 0002008790-26-000006 · form4-07152026_100742.xml · derivative · entry 2

Borie Dominique Christian · CIK 0002008790 · Chief Medical Officer · Head of Research & Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,000

Underlying: Common Stock · 63,000 shares

Expires 2036-07-13

F2 · derivative.exercise_date: The stock option becomes exercisable in equal quarterly installments over four years from July 13, 2026, subject to the reporting person's continued service with the issuer through each vest date.

Read SEC document
July 13, 2026 Filed Jul 15, 2026 22:59 UTC
Borie Dominique ChristianChief Medical Officer · Head of Research & Development
GrantCommon Stock 31,500 $0.00 $0.00
Disclosure

SEC source: 0002008790-26-000006 · form4-07152026_100742.xml · nonDerivative · entry 1

Borie Dominique Christian · CIK 0002008790 · Chief Medical Officer · Head of Research & Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,500

F1 · shares: Represents the grant of restricted stock units ("RSUs"). The shares subject to the RSU vest in equal quarterly installments over four years from July 13, 2026, subject to the reporting person's continued service with the issuer through each vest date.

Read SEC document
July 09, 2026 Filed Jul 10, 2026 19:36 UTC
Sarraf PashaDirector
GrantCommon Stock 21,800 $0.00 $0.00
Disclosure

SEC source: 0002059447-26-000004 · form4-07102026_110706.xml · nonDerivative · entry 1

Sarraf Pasha · CIK 0002059447 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,595

F1 · shares: Represents the grant of restricted stock units ("RSUs"). One-third of the shares subject to the RSUs vest on each of July 9, 2027, July 9, 2028, and July 9, 2029, subject to the reporting person's continued service with the issuer through each such vest date.

F2 · balance_after: Total holdings held after the transaction reflects a 1-for-30 reverse split of the issuer's stock effected on April 22, 2026.

Read SEC document
July 09, 2026 Filed Jul 10, 2026 23:33 UTC
Ray SumitaChief Legal Compliance Officer · Corporate Secretary
GrantCommon Stock · Derivative 54,589 $0.00 $0.00
Disclosure

SEC source: 0001579629-26-000004 · form4-07102026_110713.xml · derivative · entry 2

Ray Sumita · CIK 0001579629 · Chief Legal Compliance Officer · Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,589

Underlying: Common Stock · 54,589 shares

Expires not disclosed

F2 · derivative.exercise_price: Represents the grant of performance stock units ("PSUs"). The PSUs are subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration.

F2 · derivative.exercise_date: Represents the grant of performance stock units ("PSUs"). The PSUs are subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration.

F2 · derivative.expiration_date: Represents the grant of performance stock units ("PSUs"). The PSUs are subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration.

Read SEC document
July 09, 2026 Filed Jul 10, 2026 23:33 UTC
Ray SumitaChief Legal Compliance Officer · Corporate Secretary
GrantCommon Stock 54,589 $0.00 $0.00
Disclosure

SEC source: 0001579629-26-000004 · form4-07102026_110713.xml · nonDerivative · entry 1

Ray Sumita · CIK 0001579629 · Chief Legal Compliance Officer · Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,178

F1 · shares: Represents that grant of restricted stock units ("RSUs"). The shares subject to the RSUs vest in equal quarterly installments over a period of forty-eight (48) months, measured from the date of grant, subject to the reporting person's continued service with the issuer through each vest date.

Read SEC document
July 09, 2026 Filed Jul 10, 2026 23:37 UTC GrantCommon Stock 21,800 $0.00 $0.00
Disclosure

SEC source: 0001820365-26-000009 · form4-07102026_110706.xml · nonDerivative · entry 1

Camardo Daniel A. · CIK 0001820365 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,800

F1 · shares: Represents the grant of restricted stock units ("RSUs"). One-third of the shares subject to the RSUs vest on each of July 9, 2027, July 9, 2028, and July 9, 2029, subject to the reporting person's continued service with the issuer through each such vest date.

Read SEC document
July 09, 2026 Filed Jul 10, 2026 23:37 UTC GrantCommon Stock 21,800 $0.00 $0.00
Disclosure

SEC source: 0001974756-26-000004 · form4-07102026_110755.xml · nonDerivative · entry 1

Garzone Pamela · CIK 0001974756 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,800

F1 · shares: Represents the grant of restricted stock units ("RSUs"). One-third of the shares subject to the RSUs vest on each of July 9, 2027, July 9, 2028, and July 9, 2029, subject to the reporting person's continued service with the issuer through each such vest date.

Read SEC document
July 09, 2026 Filed Jul 10, 2026 23:35 UTC GrantCommon Stock 21,800 $0.00 $0.00
Disclosure

SEC source: 0002137444-26-000007 · form4-07102026_110702.xml · nonDerivative · entry 1

Meehan Viola Mong · CIK 0002137444 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,800

F1 · shares: Represents the grant of restricted stock units ("RSUs"). One-third of the shares subject to the RSUs vest on each of July 9, 2027, July 9, 2028, and July 9, 2029, subject to the reporting person's continued service with the issuer through each such vest date.

Read SEC document
July 09, 2026 Filed Jul 10, 2026 23:34 UTC
Meluzio Michael VincentVP, Prin. Accounting Officer
GrantCommon Stock · Derivative 40,942 $0.00 $0.00
Disclosure

SEC source: 0002138368-26-000005 · form4-07102026_110720.xml · derivative · entry 2

Meluzio Michael Vincent · CIK 0002138368 · VP, Prin. Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,942

Underlying: Common Stock · 40,942 shares

Expires not disclosed

F2 · derivative.exercise_price: Represents the grant of performance stock units ("PSUs"). The PSUs are subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration.

F2 · derivative.exercise_date: Represents the grant of performance stock units ("PSUs"). The PSUs are subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration.

F2 · derivative.expiration_date: Represents the grant of performance stock units ("PSUs"). The PSUs are subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration.

Read SEC document
July 09, 2026 Filed Jul 10, 2026 23:34 UTC
Meluzio Michael VincentVP, Prin. Accounting Officer
GrantCommon Stock 40,942 $0.00 $0.00
Disclosure

SEC source: 0002138368-26-000005 · form4-07102026_110720.xml · nonDerivative · entry 1

Meluzio Michael Vincent · CIK 0002138368 · VP, Prin. Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,942

F1 · shares: Represents that grant of restricted stock units ("RSUs"). The shares subject to the RSUs vest in equal quarterly installments over a period of forty-eight (48) months, measured from the date of grant, subject to the reporting person's continued service with the issuer through each vest date.

Read SEC document
July 09, 2026 Filed Jul 10, 2026 23:32 UTC
Lin Shao-LeeDirector · Chief Executive Officer
GrantCommon Stock · Derivative 327,537 $0.00 $0.00
Disclosure

SEC source: 0001725092-26-000006 · form4-07102026_110711.xml · derivative · entry 2

Lin Shao-Lee · CIK 0001725092 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 327,537

Underlying: Common Stock · 327,537 shares

Expires not disclosed

F2 · derivative.exercise_price: Represents the grant of performance stock units ("PSUs"). The PSUs are subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration.

F2 · derivative.exercise_date: Represents the grant of performance stock units ("PSUs"). The PSUs are subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration.

F2 · derivative.expiration_date: Represents the grant of performance stock units ("PSUs"). The PSUs are subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration.

Read SEC document
July 09, 2026 Filed Jul 10, 2026 23:32 UTC
Lin Shao-LeeDirector · Chief Executive Officer
GrantCommon Stock 327,537 $0.00 $0.00
Disclosure

SEC source: 0001725092-26-000006 · form4-07102026_110711.xml · nonDerivative · entry 1

Lin Shao-Lee · CIK 0001725092 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 655,074

F1 · shares: Represents that grant of restricted stock units ("RSUs"). The shares subject to the RSUs vest in equal quarterly installments over a period of forty-eight (48) months, measured from the date of grant, subject to the reporting person's continued service with the issuer through each vest date.

Read SEC document
July 09, 2026 Filed Aug 28, 2026 17:05 UTC Amendment
Sarraf PashaDirector
GrantCommon Stock 18,400 $0.00 $0.00
Disclosure

SEC source: 0002059447-26-000006 · form4a-08282026_090818.xml · nonDerivative · entry 1

Sarraf Pasha · CIK 0002059447 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,195

F1 · shares: This amendment is being filed solely to correct an administrative calculation error in Column 4 of Table I of the original filing relating to a grant of restricted stock units ("RSUs") to the Reporting Person, which resulted in the number of securities acquired by the Reporting Person being overstated. The original filing incorrectly reported 21,800 shares; the correct amount of shares acquired is 18,400. As a result of this correction, the total amount of securities beneficially owned following the reported transaction in Column 5 has been updated to 29,195. One-third of the shares subject to the RSU vest on each of July 9, 2027, July 9, 2028 and July 9, 2029, subject to the Reporting Person's continued service with the Issuer through each such vest date.

Read SEC document
July 09, 2026 Filed Aug 28, 2026 17:04 UTC Amendment GrantCommon Stock 18,900 $0.00 $0.00
Disclosure

SEC source: 0001974756-26-000006 · form4a-08282026_090821.xml · nonDerivative · entry 1

Garzone Pamela · CIK 0001974756 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,900

F1 · shares: This amendment is being filed solely to correct an administrative calculation error in Column 4 of Table I of the original filing relating to a grant of restricted stock units ("RSUs") to the Reporting Person, which resulted in the number of securities acquired by the Reporting Person being overstated. The original filing incorrectly reported 21,800 shares; the correct amount of shares acquired is 18,900. As a result of this correction, the total amount of securities beneficially owned following the reported transaction in Column 5 has been updated to 18,900. One-third of the shares subject to the RSU vest on each of July 9, 2027, July 9, 2028 and July 9, 2029, subject to the Reporting Person's continued service with the Issuer through each such vest date.

Read SEC document
June 01, 2026 Filed Jun 3, 2026 21:30 UTC
Lin Shao-LeeDirector · Chief Executive Officer
PurchaseCommon Stock Warrants (Right to Buy) · Derivative 45,453 Not disclosed Strike: $11.00 Not disclosed
Disclosure

SEC source: 0001725092-26-000004 · form4-06032026_090611.xml · derivative · entry 2

Lin Shao-Lee · CIK 0001725092 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 45,453

Underlying: Common Stock · 45,453 shares

Expires 2031-05-04

F2 · price: On April 30, 2026, the Issuer entered into a securities purchase agreement (the "Purchase Agreement") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold pre-funded warrants and accompanying warrants to purchase shares of common stock in a private placement that closed on May 4, 2026. The purchase price for each pre-funded warrant and accompanying warrants to purchase one-half of one share of common stock was $11.00. The pre-funded warrants and accompanying warrants became exercisable on June 1, 2026, following approval by the Issuer's stockholders of the issuance of common stock upon exercise of the pre-funded warrants and accompanying warrants in accordance with applicable listing rules of the Nasdaq Stock Market, including Nasdaq Listing Rule 5636, at the Issuer's Special Meeting of Stockholders held on June 1, 2026.

F3 · ownership.nature: The securities are held by the Shao-Lee Lin Trust, DTD 3/13/2023.

Read SEC document
June 01, 2026 Filed Jun 3, 2026 21:30 UTC
Lin Shao-LeeDirector · Chief Executive Officer
PurchasePre-Funded Warrants (Right to Buy) · Derivative 90,906 $11.00 Strike: $0.00 $999,966.00
Disclosure

SEC source: 0001725092-26-000004 · form4-06032026_090611.xml · derivative · entry 1

Lin Shao-Lee · CIK 0001725092 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 90,906

Underlying: Common Stock · 90,906 shares

Expires not disclosed

F2 · price: On April 30, 2026, the Issuer entered into a securities purchase agreement (the "Purchase Agreement") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold pre-funded warrants and accompanying warrants to purchase shares of common stock in a private placement that closed on May 4, 2026. The purchase price for each pre-funded warrant and accompanying warrants to purchase one-half of one share of common stock was $11.00. The pre-funded warrants and accompanying warrants became exercisable on June 1, 2026, following approval by the Issuer's stockholders of the issuance of common stock upon exercise of the pre-funded warrants and accompanying warrants in accordance with applicable listing rules of the Nasdaq Stock Market, including Nasdaq Listing Rule 5636, at the Issuer's Special Meeting of Stockholders held on June 1, 2026.

F1 · derivative.expiration_date: The securities do not have an expiration date.

F3 · ownership.nature: The securities are held by the Shao-Lee Lin Trust, DTD 3/13/2023.

Read SEC document
June 01, 2026 Filed Jul 30, 2026 20:35 UTC Amendment
Lin Shao-LeeDirector · Chief Executive Officer
GrantCommon Stock Warrants (Right to Buy) · Derivative 45,453 Not disclosed Strike: $11.00 Not disclosed
Disclosure

SEC source: 0001725092-26-000009 · form4a-07302026_080752.xml · derivative · entry 2

Lin Shao-Lee · CIK 0001725092 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 45,453

Underlying: Common Stock · 45,453 shares

Expires 2031-05-04

F1 · kind: This amendment is filed solely to correct the transaction code reported in Column 4 of Table II. The transactions reported herein were approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended, prior to the issuance of the applicable securities. All other information in the original filing remains unchanged.

F3 · price: On April 30, 2026, the Issuer entered into a securities purchase agreement (the "Purchase Agreement") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold pre-funded warrants and accompanying warrants to purchase shares of common stock in a private placement that closed on May 4, 2026. The purchase price for each pre-funded warrant and accompanying warrants to purchase one-half of one share of common stock was $11.00. The pre-funded warrants and accompanying warrants became exercisable on June 1, 2026, following approval by the Issuer's stockholders of the issuance of common stock upon exercise of the pre-funded warrants and accompanying warrants in accordance with applicable listing rules of the Nasdaq Stock Market, including Nasdaq Listing Rule 5636, at the Issuer's Special Meeting of Stockholders held on June 1, 2026.

F4 · ownership.nature: The securities are held by the Shao-Lee Lin Trust, DTD 3/13/2023.

Read SEC document
June 01, 2026 Filed Jul 30, 2026 20:35 UTC Amendment
Lin Shao-LeeDirector · Chief Executive Officer
GrantPre-Funded Warrants (Right to Buy) · Derivative 90,906 $11.00 Strike: $0.00 $999,966.00
Disclosure

SEC source: 0001725092-26-000009 · form4a-07302026_080752.xml · derivative · entry 1

Lin Shao-Lee · CIK 0001725092 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 90,906

Underlying: Common Stock · 90,906 shares

Expires not disclosed

F1 · kind: This amendment is filed solely to correct the transaction code reported in Column 4 of Table II. The transactions reported herein were approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended, prior to the issuance of the applicable securities. All other information in the original filing remains unchanged.

F3 · price: On April 30, 2026, the Issuer entered into a securities purchase agreement (the "Purchase Agreement") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold pre-funded warrants and accompanying warrants to purchase shares of common stock in a private placement that closed on May 4, 2026. The purchase price for each pre-funded warrant and accompanying warrants to purchase one-half of one share of common stock was $11.00. The pre-funded warrants and accompanying warrants became exercisable on June 1, 2026, following approval by the Issuer's stockholders of the issuance of common stock upon exercise of the pre-funded warrants and accompanying warrants in accordance with applicable listing rules of the Nasdaq Stock Market, including Nasdaq Listing Rule 5636, at the Issuer's Special Meeting of Stockholders held on June 1, 2026.

F2 · derivative.expiration_date: The securities do not have an expiration date.

F4 · ownership.nature: The securities are held by the Shao-Lee Lin Trust, DTD 3/13/2023.

Read SEC document
May 30, 2026 Filed Jun 3, 2026 00:42 UTC GrantStock Option (Right to Buy) · Derivative 1,626 $0.00 Strike: $21.90 $0.00
Disclosure

SEC source: 0002137444-26-000005 · form4-06032026_120657.xml · derivative · entry 1

Meehan Viola Mong · CIK 0002137444 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,626

Underlying: Common Stock · 1,626 shares

Expires 2036-05-29

F1 · derivative.exercise_date: The shares underlying the option are scheduled to vest over three years with one-third vesting on the one-year anniversary of the grant date and the balance vesting in eight equal quarterly installments.

Read SEC document
May 30, 2026 Filed Jun 8, 2026 20:25 UTC GrantStock Option (Right to Buy) · Derivative 1,626 $0.00 Strike: $21.90 $0.00
Disclosure

SEC source: 0001820365-26-000006 · form4-06082026_080603.xml · derivative · entry 1

Camardo Daniel A. · CIK 0001820365 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,626

Underlying: Common Stock · 1,626 shares

Expires 2036-05-29

F1 · derivative.exercise_date: The shares underlying the option are scheduled to vest over three years with one-third vesting on the one-year anniversary of the grant date and the balance vesting in eight equal quarterly installments.

Read SEC document
May 03, 2026 Filed May 7, 2026 20:00 UTC
Lin Shao-LeeDirector · CHIEF EXECUTIVE OFFICER
GrantStock Option (right to buy) · Derivative 655,074 $0.00 Strike: $30.42 $0.00
Disclosure

SEC source: 0001193125-26-211806 · ownership.xml · derivative · entry 2

Lin Shao-Lee · CIK 0001725092 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 655,074

Underlying: Common Stock · 655,074 shares

Expires 2036-05-02

F1 · derivative.exercise_date: This stock option becomes exercisable in 48 equal monthly installments beginning on April 30, 2026.

Read SEC document
May 03, 2026 Filed May 7, 2026 20:00 UTC
Lin Shao-LeeDirector · CHIEF EXECUTIVE OFFICER
GrantCommon Stock 327,537 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-211806 · ownership.xml · nonDerivative · entry 1

Lin Shao-Lee · CIK 0001725092 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 327,537

Read SEC document
April 09, 2026 Filed Apr 10, 2026 20:00 UTC
Baker Daniel G.CHIEF DEVELOPMENT OFFICER
GrantStock Option (right to buy) · Derivative 100,000 $0.00 Strike: $0.29 $0.00
Disclosure

SEC source: 0001193125-26-151200 · ownership.xml · derivative · entry 1

Baker Daniel G. · CIK 0002046802 · CHIEF DEVELOPMENT OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2036-04-08

F1 · derivative.exercise_date: This stock option becomes exercisable over four years, with 25% vesting on the one year anniversary of the grant date and the remainder vesting in equal, semi-annual installments thereafter.

Read SEC document
April 09, 2026 Filed Apr 10, 2026 20:00 UTC
Warren LucindaCHIEF BUSINESS OFFICER
GrantStock Option (right to buy) · Derivative 250,000 $0.00 Strike: $0.29 $0.00
Disclosure

SEC source: 0001193125-26-151201 · ownership.xml · derivative · entry 1

Warren Lucinda · CIK 0002035620 · CHIEF BUSINESS OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2036-04-08

F1 · derivative.exercise_date: This stock option becomes exercisable over four years, with 25% vesting on the one year anniversary of the grant date and the remainder vesting in equal, semi-annual installments thereafter.

Read SEC document
April 09, 2026 Filed Apr 10, 2026 20:00 UTC
Sandercock ColinSVP, GENERAL COUNSEL
GrantStock Option (right to buy) · Derivative 200,000 $0.00 Strike: $0.29 $0.00
Disclosure

SEC source: 0001193125-26-151202 · ownership.xml · derivative · entry 1

Sandercock Colin · CIK 0001724870 · SVP, GENERAL COUNSEL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2036-04-08

F1 · derivative.exercise_date: This stock option becomes exercisable over four years, with 25% vesting on the one year anniversary of the grant date and the remainder vesting in equal, semi-annual installments thereafter.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 16:00 UTC
Sarraf PashaDirector
GrantStock Option (right to buy) · Derivative 24,400 $0.00 Strike: $0.34 $0.00
Disclosure

SEC source: 0001193125-26-004354 · ownership.xml · derivative · entry 1

Sarraf Pasha · CIK 0002059447 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,400

Underlying: Common Stock · 24,400 shares

Expires 2036-01-01

F1 · shares: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy.

F2 · derivative.exercise_date: This stock option becomes fully exercisable on the first anniversary of the grant date.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 21:00 UTC GrantStock Option (right to buy) · Derivative 24,400 $0.00 Strike: $0.34 $0.00
Disclosure

SEC source: 0001193125-26-004358 · ownership.xml · derivative · entry 1

Broadfoot Jill Marie · CIK 0001305178 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,400

Underlying: Common Stock · 24,400 shares

Expires 2036-01-01

F1 · shares: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy.

F2 · derivative.exercise_date: This stock option becomes fully exercisable on the first anniversary of the grant date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.